Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Kyverna Therapeutics, Inc. | Chief Financial Officer | Common Stock | 44K | May 28, 2024 | Direct | ||
Kyverna Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 2.19K | May 28, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
KYTX | Kyverna Therapeutics, Inc. | May 28, 2024 | 4 | $13.2K | 4 | May 29, 2024 | Chief Financial Officer |
KYTX | Kyverna Therapeutics, Inc. | Feb 7, 2024 | 0 | $0 | 3 | Feb 7, 2024 | Chief Financial Officer |